Coagulation activation in autoimmune bullous diseases

A. V. Marzano, A. Tedeschi, D. Spinelli, D. Fanoni, C. Crosti, M. Cugno

Research output: Contribution to journalArticlepeer-review


The main autoimmune blistering skin disorders are pemphigus vulgaris (PV) and bullous pemphigoid (BP). They differ in the inflammatory infiltrate, which is more intense in BP. Inflammation is known to activate coagulation in several disorders. Local and systemic activation of coagulation was evaluated in BP and PV. We studied 20 BP patients (10 active and 10 remittent), 23 PV patients (13 active and 10 remittent) and 10 healthy subjects. The coagulation markers prothrombin fragment F1+2 and D-dimer were measured by enzyme-immunoassays in plasma. The presence of tissue factor (TF), the main initiator of blood coagulation, was evaluated immunohistochemically in skin specimens from 10 patients with active PV, 10 patients with active BP and 10 controls. Plasma F1+2 and D-dimer levels were significantly high in active BP (P = 0·001), whereas in active PV the levels were normal. During remission, F1+2 and D-dimer plasma levels were normal in both BP and PV. TF immunoreactivity was found in active BP but neither in active PV nor in normal skin. TF reactivity scores were higher in active BP than in controls or active PV (P = 0·0001). No difference in TF scores was found between active PV and controls. BP is associated with coagulation activation, which is lacking in PV. This suggests that BP but not PV patients have an increased thrombotic risk. The observation that thrombotic complications occur more frequently in BP than in PV further supports this view.

Original languageEnglish
Pages (from-to)31-36
Number of pages6
JournalClinical and Experimental Immunology
Issue number1
Publication statusPublished - Oct 2009


  • Bullous pemphigoid
  • Coagulation
  • Eosinophil
  • Pemphigus vulgaris
  • Tissue factor

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy


Dive into the research topics of 'Coagulation activation in autoimmune bullous diseases'. Together they form a unique fingerprint.

Cite this